Heo, Y.J.; Park, J.; Lee, N.; Choi, S.-E.; Jeon, J.Y.; Han, S.J.; Kim, D.J.; Lee, K.W.; Kim, H.J.
Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease. Int. J. Mol. Sci. 2025, 26, 4054.
https://doi.org/10.3390/ijms26094054
AMA Style
Heo YJ, Park J, Lee N, Choi S-E, Jeon JY, Han SJ, Kim DJ, Lee KW, Kim HJ.
Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025; 26(9):4054.
https://doi.org/10.3390/ijms26094054
Chicago/Turabian Style
Heo, Yu Jung, Jieun Park, Nami Lee, Sung-E Choi, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Kwan Woo Lee, and Hae Jin Kim.
2025. "Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease" International Journal of Molecular Sciences 26, no. 9: 4054.
https://doi.org/10.3390/ijms26094054
APA Style
Heo, Y. J., Park, J., Lee, N., Choi, S.-E., Jeon, J. Y., Han, S. J., Kim, D. J., Lee, K. W., & Kim, H. J.
(2025). Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences, 26(9), 4054.
https://doi.org/10.3390/ijms26094054
